DAVITA INC. Goodwill, Foreign Currency Translation Gain (Loss)
DAVITA INC. (DVA) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$98.19 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-02-11
- DAVITA INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2022-03-31 was -$22.22M, a 166.61% decline year-over-year.
- DAVITA INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2021-12-31 was $12.93M.
- DAVITA INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2021-09-30 was $27.67M.
- DAVITA INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2021-06-30 was -$29.59M.
- DAVITA INC. goodwill, foreign currency translation gain (loss) for fiscal 2025 was -$98.19M, a 217.99% decline from fiscal 2024.
- DAVITA INC. goodwill, foreign currency translation gain (loss) for fiscal 2024 was $83.22M.
- DAVITA INC. goodwill, foreign currency translation gain (loss) for fiscal 2023 was -$36.31M, a 336.89% decline from fiscal 2022.
- DAVITA INC. goodwill, foreign currency translation gain (loss) for fiscal 2022 was $15.33M, a 65.45% decline from fiscal 2021.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$98.19M 10-K · filed 2026-02-11 | ||||
| 2024-12-31 | $83.22M 10-K · filed 2026-02-11 | ||||
| 2023-12-31 | -$36.31M 10-K · filed 2025-02-13 | ||||
| 2022-12-31 | $15.33M 10-K · filed 2024-02-14 | ||||
| 2022-03-31 | -$22.22M 10-Q · filed 2022-05-05 | -$9.29M derived: sum of 2 quarters · filed 2023-02-22 | $18.38M derived: sum of 3 quarters · filed 2023-02-22 | -$11.21M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-12-31 | $12.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $40.60M derived: sum of 2 quarters · filed 2023-02-22 | $11.01M derived: sum of 3 quarters · filed 2023-02-22 | $44.37M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $27.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$1.92M derived: sum of 2 quarters · filed 2021-10-28 | $31.44M 10-Q · filed 2021-10-28 | $515.00K derived: sum of 4 quarters · filed 2022-02-11 | |
| 2021-06-30 | -$29.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $3.77M 10-Q · filed 2021-08-03 | -$27.16M derived: sum of 3 quarters · filed 2022-02-11 | -$36.26M derived: sum of 4 quarters · filed 2022-02-11 | |
| 2021-03-31 | $33.36M 10-Q · filed 2021-04-29 | $2.43M derived: sum of 2 quarters · filed 2022-02-11 | -$6.67M derived: sum of 3 quarters · filed 2022-02-11 | -$11.19M derived: sum of 4 quarters · filed 2022-02-11 | |
| 2020-12-31 | -$30.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | -$40.03M derived: sum of 2 quarters · filed 2022-02-11 | -$44.54M derived: sum of 3 quarters · filed 2022-02-11 | -$9.71M 10-K · filed 2022-02-11 | |
| 2020-09-30 | -$9.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$13.62M derived: sum of 2 quarters · filed 2020-10-29 | $21.21M 10-Q · filed 2020-10-29 | $12.22M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2020-06-30 | -$4.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $30.32M 10-Q · filed 2020-07-30 | $21.33M derived: sum of 3 quarters · filed 2021-02-12 | $52.13M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2020-03-31 | $34.83M 10-Q · filed 2020-05-05 | $25.84M derived: sum of 2 quarters · filed 2021-02-12 | $56.64M derived: sum of 3 quarters · filed 2021-02-12 | $64.70M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-12-31 | -$8.99M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $21.81M derived: sum of 2 quarters · filed 2021-02-12 | $29.87M derived: sum of 3 quarters · filed 2021-02-12 | $19.66M 10-K · filed 2021-02-12 | -$19.66M 10-K · filed 2020-02-21 |
| 2019-09-30 | $30.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $38.86M derived: sum of 2 quarters · filed 2019-11-07 | $28.65M 10-Q · filed 2019-11-07 | $25.25M derived: sum of 4 quarters · filed 2020-02-21 | |
| 2019-06-30 | $8.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$2.15M 10-Q · filed 2019-08-02 | -$5.54M derived: sum of 3 quarters · filed 2020-02-21 | -$10.77M derived: sum of 4 quarters · filed 2020-02-21 | |
| 2019-03-31 | -$10.21M 10-Q · filed 2019-05-07 | -$13.60M derived: sum of 2 quarters · filed 2020-02-21 | -$18.82M derived: sum of 3 quarters · filed 2020-02-21 | -$50.55M derived: sum of 4 quarters · filed 2020-02-21 | |
| 2018-12-31 | -$3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$8.61M derived: sum of 2 quarters · filed 2020-02-21 | -$40.34M derived: sum of 3 quarters · filed 2020-02-21 | -$28.06M 10-K · filed 2020-02-21 | |
| 2018-09-30 | -$5.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$36.94M derived: sum of 2 quarters · filed 2018-11-07 | -$24.67M 10-Q · filed 2018-11-07 | -$17.60M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2018-06-30 | -$31.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$19.45M 10-Q · filed 2018-08-01 | -$12.38M derived: sum of 3 quarters · filed 2019-02-22 | -$364.00K derived: sum of 4 quarters · filed 2019-02-22 | |
| 2018-03-31 | $12.27M 10-Q · filed 2018-05-03 | $19.34M derived: sum of 2 quarters · filed 2019-02-22 | $31.36M derived: sum of 3 quarters · filed 2019-02-22 | $53.96M derived: sum of 4 quarters · filed 2019-02-22 | |
| 2017-12-31 | $7.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $19.09M derived: sum of 2 quarters · filed 2019-02-22 | $41.69M derived: sum of 3 quarters · filed 2019-02-22 | $46.45M 10-K · filed 2019-02-22 | |
| 2017-09-30 | $12.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $34.62M derived: sum of 2 quarters · filed 2017-11-07 | $39.38M 10-Q · filed 2017-11-07 | $25.04M derived: sum of 4 quarters · filed 2018-02-23 | |
| 2017-06-30 | $22.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $27.37M 10-Q · filed 2017-08-01 | $13.03M derived: sum of 3 quarters · filed 2018-02-23 | $15.11M derived: sum of 4 quarters · filed 2018-02-23 | |
| 2017-03-31 | $4.76M 10-Q · filed 2017-05-02 | -$9.58M derived: sum of 2 quarters · filed 2018-02-23 | -$7.50M derived: sum of 3 quarters · filed 2018-02-23 | ||
| 2016-12-31 | -$14.34M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$12.26M derived: sum of 2 quarters · filed 2018-02-23 | -$8.82M 10-K · filed 2018-02-23 | ||
| 2016-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $5.53M 10-Q · filed 2016-11-02 | |||
| 2016-06-30 | $3.45M 10-Q · filed 2016-08-08 | ||||
| 2015-12-31 | -$16.29M 10-K · filed 2017-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |